Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01346410 · ClinicalTrials.gov registry record · NA
Stereotactic Body Radiotherapy for Unresectable Pancreatic Cancer
A NA study, sponsored by Mercy Research.
- Completed
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT01346410 is a NA study that has completed, run by Mercy Research. The registered enrollment target is 1 participants.
The verdict
NCT01346410, a NA study, has completed, sponsored by Mercy Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study will evaluate the local control rate as well as acute and late toxicity rates of stereotactic body radiotherapy (SBRT) for the treatment of unresectable pancreatic cancer.
Interventions
- RADIATION Stereotactic Body Radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2008-09 |
| Est. Completion | 2012-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01346410
The ClinicalTrials.gov registry entry for NCT01346410 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mercy Research, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stereotactic Body Radiotherapy is the first listed.
NCT01346410 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01346410 about?
NCT01346410 is a clinical study titled "Stereotactic Body Radiotherapy for Unresectable Pancreatic Cancer". This study will evaluate the local control rate as well as acute and late toxicity rates of stereotactic body radiotherapy (SBRT) for the treatment of unresectable pancreatic cancer.
What is the current status of trial NCT01346410?
This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2008-09. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01346410?
The interventions under investigation include: Stereotactic Body Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT01346410?
This trial is sponsored by Mercy Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.